Compare the Medical Conditions of Gulf War Veterans to Non-Deployed Veterans

12:47 EDT 25th October 2014 | BioPortfolio

Summary

Primary Hypothesis: Gulf War veterans will have an equal prevalence or mean level of the following medical and psychological conditions frequently reported in the literature compared to a control group of nondeployed veterans: (1) chronic fatigue syndrome, (2) fibromyalgia, (3) post-traumatic stress disorder, (4) neurologic abnormalities, including peripheral neuropathy and cognitive dysfunction, and (5) general health status.

Description

* 1,000 Gulf War veterans, spouses, & children and 1,000 non-deployed Gulf War era veterans, spouses, & children.

Primary Hypothesis: Gulf War veterans will have an equal prevalence or mean level of the following medical and psychological conditions frequently reported in the literature compared to a control group of nondeployed veterans: (1) chronic fatigue syndrome, (2) fibromyalgia, (3) post-traumatic stress disorder, (4) neurologic abnormalities, including peripheral neuropathy and cognitive dysfunction, and (5) general health status.

Secondary Hypotheses: (1) Medical conditions that were reported as more frequent among Gulf War veterans compared to nondeployed veterans in the self-reported data in Phase I will be of equal prevalence in the two groups upon objective clinical examination. These include arthritis, dermatitis, hypertension, bronchitis, and asthma. (2) The prevalence of the above medical conditions in the primary hypotheses and secondary hypothesis (#1) will be equal between the spouses of Gulf War veterans and those of nondeployed veterans. (3) The prevalence of major birth defects found on a pediatric physical examination of veterans' biologic children conceived after the war to Gulf War veterans and nondeployed veterans will be equal; the prevalence of medical conditions in children living in the veterans' household, whether conceived before or after the war, for Gulf War veterans and nondeployed veteran will be equal.

Intervention: This is an observational study.

Primary outcomes variables: chronic fatigue syndrome; post-traumatic stress disorder, fibromyalgia; peripheral neuropathy; cognitive dysfunction; and general health status: physical component and mental component.

Study Abstract: In response to a legislative mandate, the VA initiated a survey entitled A National Health Survey of Persian Gulf Veterans and Their Families. The survey was designed as a retrospective cohort study in which the health of a population-based sample of 15,000 troops deployed into the Persian Gulf area was compared to those of 15,000 troops not deployed in the Persian Gulf area. The survey was to be conducted in three phases. In Phase I of the study, a structured health questionnaire was mailed to each of the 30,000 Persian Gulf War-era veterans who were sampled for the survey. Up to four follow-up mailings were sent to non-respondents to increase the response rate in a six-month period. In Phase II, telephone interviews of a sample of 8,000 non-respondents and a review of selected medical records for a sample of 4,000 veteran respondents were conducted. Through additional telephone interviews with non-respondents, the potential for non-participant bias was evaluated. The medical records review helped in assessing validity of selected self-reported health data (clinic visit, hospitalization, pregnancy outcomes, birth defects among children, infant deaths, etc.).

The present protocol represents Phase III of the study--clinical examinations of a sample of 1,000 Gulf War (GW) veterans and their spouses and children and 1,000 Gulf War era nondeployed veterans and their spouses and children. Results from Phase I indicated that the prevalence of several self-reported health conditions are elevated in the GW veterans compared to the control group. The overall purpose of the Phase III study is to corroborate these findings through more objective clinical examination.

A sample from a pool of Phase I and Phase II Persian Gulf War veterans and Persian Gulf era nondeployed veterans were generated. Dr. Kang's office provided the 16 participating medical centers with names and phone numbers of veterans to be contacted. Each medical center examined an average of 125 veterans, 95 spouses, and 123 children over a period of 30 months. The VA medical centers were strategically selected so that there was a VA medical center within driving distance of the majority of the families sampled. Veterans were contacted first by letter and then by telephone through the site closest to their home and invited to participate in the study. Exams were scheduled for the veteran and spouse/children if they were participating. Data from these exams were sent to the Hines CSPCC for cleaning and analysis. Travel arrangements and expenses were provided for the participants and they were reimbursed for their time.

Characteristics of Participants: Mean age for deployed veterans who were examined was 38.9 yrs. compared with 40.7 yrs. for non-deployed veterans who were examined (p<.0001). Mean income was $46,800 for deployed and $52,000 for non-deployed participants (p=.003). Non-deployed participants were more likely to be white (81.0% vs. 76.4%, p=.03), to be married (72.3% vs. 67.4%, p=.02), and to continue education past high school (42% vs. 32.5%, p<.0001). Results for Veterans: Both the physical and mental component scores derived from the SF-36 were significantly lower among deployed veterans who were examined. For the physical component score, the mean for the deployed group was 48.2 (s.d. 9.8) compared with 50.8 (s.d. 8.3) for the non-deployed group, p<.0001. The mental component score averaged 49.6 (s.d. 10.2) for the deployed group and 53.7 (s.d. 7.9) for the non-deployed group, p<.0001. There was a weak trend for a higher prevalence of fibromyalgia in the deployed group (3.1%) than in the non-deployed group (1.9%), [odds ratio 1.64, 95% confidence interval (.94, 2.87), p=.09]. There was a higher prevalence of chronic fatigue syndrome among deployed (1.6%) than non-deployed (0.4%), [odds ratio 4.58, 95% confidence interval (1.53, 13.64), p=.003]. Among the seven cognitive dysfunction factors, there was a trend towards a higher prevalence of impaired attention/working memory among deployed (6.6%) than non-deployed (4.2%), [odds ratio 1.60, 95% confidence interval (1.10, 2.35), p=.02]. PTSD after the Gulf War was more prevalent among deployed (10.1%) than non-deployed participants (3.2%), [odds ratio 3.41, 95% confidence interval (2.30, 5.05), p<.0001]. No differences were found for peripheral neuropathy and 6 of the 7 factors defined to assess cognitive dysfunction. Among secondary outcome measures, several categories of skin conditions were found to be more prevalent among deployed veterans. Results for Spouses: The mean score for the mental component scale was lower in the spouses of deployed participants (50.3 (s.d. 9.9)) than in the spouses of non-deployed participants (52.6 (s.d. 8.6), p<.0001). No other outcome measures for spouses were found to be related to deployment status of the veteran. Birth Defects: No statistically significant relationship between deployment status and prevalence of birth defects among first live born offspring born after the Gulf War was found. Summary: Although participation rates were lower than anticipated, we found little evidence of participation bias. Veterans deployed to the Gulf War have higher rates of chronic fatigue syndrome and post-Gulf War onset PTSD, and poorer health-related quality of life. Attention/working memory deficits and fibromyalgia may also be related to deployment to the Gulf War. Additional Comments: Additional analytic work remains: (a) the results have not been adjusted for covariates such as age, (b) certain subgroups were oversampled and the results are not adjusted for the study's original sampling methodology, (c) analysis of subgroups that are purported to be at increased risk of health impacts due to their type of service in the Gulf War has not been done.

Study Design

Time Perspective: Retrospective

Conditions

Chronic Fatigue Syndrome

Status

Completed

Source

Department of Veterans Affairs

Results (where available)

View Results

Links

Clinical Trials [699 Associated Clinical Trials listed on BioPortfolio]

Behavioral Insomnia Therapy With Chronic Fatigue Syndrome

The purpose of this study is to determine how best to manage the sleep problems of people with Chronic Fatigue Syndrome. This study is being conducted to determine how improvements in sle...

The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial

The purpose of this study IS to - explore the underlying pathophysiology of chronic fatigue syndrome (CFS) in adolescents, particularly focusing on genetics, infections/immunology...

B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome

Based on pilot patient observations, and experience from the prior study KTS-1-2008, the investigators anticipate that chronic fatigue syndrome patients may benefit from B-cell depletion t...

B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome

Based on pilot patient observations, and experience from the prior study KTS-1-2008, the investigators anticipate that severely affected chronic fatigue syndrome patients may benefit from ...

Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome

The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS). Epstein Bar...

PubMed Articles [12226 Associated PubMed Articles listed on BioPortfolio]

Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis.

Considerable controversy has transpired regarding the core features of myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS). Current case definitions differ in the number and types of sym...

A Study of the Protective Effect of Triticum aestivum L. in an Experimental Animal Model of Chronic Fatigue Syndrome.

Oxidative stress plays a major role in the pathogenesis of chronic fatigue syndrome (CFS). Keeping in view the proven antioxidant activity of Triticum aestivum L., this study has been undertaken to ex...

Diagnosing Chronic Fatigue Syndrome in South Asians: Lessons from a Secondary Analysis of a UK Qualitative Study.

Chronic fatigue syndrome/myalgic encephalitis (CFS/ME) is rarely diagnosed in South Asia (SA), although the symptoms of this condition are seen in the population. Lessons from UK based South Asian, Bl...

Impaired Range of Motion of Limbs and Spine in Chronic Fatigue Syndrome.

To determine whether adolescents and young adults with chronic fatigue syndrome (CFS) have a greater prevalence of impaired range of motion (ROM) of the limbs and spine than healthy control patients.

Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study.

Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disease characterized by chronic, profound, disabling, and unexplained fatigue. Although it is hypothesized that brain inflammation is ...

Medical and Biotech [MESH] Definitions

A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)

A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)

Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).

The type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; (HBLV) antibodies are elevated in patients with AIDS, Sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis.

A mental disorder characterized by chronic fatigue and concomitant physiologic symptoms.

More From BioPortfolio on "Compare the Medical Conditions of Gulf War Veterans to Non-Deployed Veterans"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Rheumatology
Latest News Clinical Trials Research Drugs Reports Corporate
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It is an active area of medical research, because of the d...

Advertisement